💊 Cabinet Fast-Tracks National Medicinal Drug Policy 2026–2030

• Policy Overview: The Cabinet of Ministers has approved the swift implementation of the new National Medicinal Drug Policy (2026–2030) to ensure equitable, sustainable, and affordable access to safe, high-quality essential medicines meeting international standards. • Framework Update: Replaces the outdated 2005 framework after preliminary update attempts stalled between 2020 and 2025. • Key Focus Areas: • Healthcare Efficiency: Promotes cost-effective, scientifically sound medical products to enhance treatment outcomes and minimize healthcare wastage. • Domestic Industry: Prioritizes strengthening local pharmaceutical manufacturing for essential medical items with certified safety, efficacy, and quality. • Supply Chain Resilience: Addresses vulnerabilities in drug supply chains, changing global market conditions, and evolving domestic public health needs.